Study guide

Excimer ablation, PRK and LASIK

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

Excimer ablation, PRK and LASIK

Key Takeaways Explain This Topic AI

Excimer photoablation changes corneal curvature, with depth depending strongly on optical-zone size.

PRK and LASIK differ in surface healing, flap effects and complication profiles.

Ablation planning requires refractive stability, surface assessment and screening for ectatic disease.

Last updated: October 2026

Keratorefractive surgery encompasses surgical techniques that alter the anterior corneal curvature to modify the total refractive power of the human eye ( + 43.00 D +43.00\text{ D} + 43.00 D out of the total + 60.00 D +60.00\text{ D} + 60.00 D ocular refractive power). By precisely reshaping the stroma, surgeons correct myopia, hyperopia, and astigmatism. A comprehensive understanding of laser-tissue interactions, stromal wound healing kinetics, biomechanical stability, and ectasia risk stratification is fundamental for the European Board of Ophthalmology Diploma (EBOD) examination.

1. Optical Physics of Excimer Laser Photoablation

The excimer (excited dimer) laser operates in the far ultraviolet spectrum at 193 nm , generated by an electrical discharge through a gaseous mixture of argon and fluorine ( ArF ). Each 193 nm photon carries an energy of 6.4 electron volts (eV) , which exceeds the intermolecular covalent binding energy of corneal peptide and collagen bonds (typically 3.6 eV 3.6\text{ eV} 3.6 eV for carbon-carbon and carbon-nitrogen bonds).

Photochemical Ablation (Photoablation)

Rather than burning or vaporising tissue through thermal heating, the 193 nm laser induces photodecomposition (photochemical ablation):

High-energy ultraviolet photons are absorbed within a microscopic superficial layer of hydrated stromal tissue ( < 1 μ m < 1\,\mu\text{m} < 1 μ m penetration depth).

Covalent molecular bonds are directly cleaved within picoseconds.

The fragmented molecular products undergo explosive supersonic expansion and ejection away from the stromal surface.

Surrounding adjacent tissue experiences negligible collateral thermal damage ( < 0.3 – 0.5 μ m < 0.3–0.5\,\mu\text{m} < 0.3–0.5 μ m thermal zone of coagulation).

Each standard laser pulse reliably ablates approximately 0.25 μ m 0.25\,\mu\text{m} 0.25 μ m of corneal stroma at a fluence of 160 – 200 mJ/cm 2 160–200\text{ mJ/cm}^2 160–200 mJ/cm 2 .

Munnerlyn's Formula for Ablation Depth

The mathematical foundation of myopic excimer photoablation was established by Charles Munnerlyn. To correct a spherical myopic error by flattening the central corneal curvature, the laser ablates a central lenticule of tissue according to the parabolic equation: t = S 2 × D 3 t = \frac{S^2 \times D}{3} t = 3 S 2 × D ​

where:

  • t t t is the central ablation depth in micrometres ( μ m \mu\text{m} μ m )
  • S S S is the diameter of the optical zone in millimetres ( mm \text{mm} mm )
  • D D D is the dioptric power of refractive correction in dioptres ( D \text{D} D )
  • The Quadratic Impact of the Optical Zone

Because the optical zone diameter ( S S S ) is squared in Munnerlyn's formula, even small increments in optical zone size produce dramatic increases in central tissue ablation. Conversely, ablation depth scales linearly with dioptric correction ( D D D ):

Myopic Correction ( D D D ) Optical Zone ( S = 5.5 mm S = 5.5\text{ mm} S = 5.5 mm ) Optical Zone ( S = 6.0 mm S = 6.0\text{ mm} S = 6.0 mm ) Optical Zone ( S = 6.5 mm S = 6.5\text{ mm} S = 6.5 mm ) Optical Zone ( S = 7.0 mm S = 7.0\text{ mm} S = 7.0 mm )

− 3.00 D -3.00\text{ D} − 3.00 D 30.25 μ m 30.25\,\mu\text{m} 30.25 μ m 36.00 μ m 36.00\,\mu\text{m} 36.00 μ m 42.25 μ m 42.25\,\mu\text{m} 42.25 μ m 49.00 μ m 49.00\,\mu\text{m} 49.00 μ m

− 6.00 D -6.00\text{ D} − 6.00 D 60.50 μ m 60.50\,\mu\text{m} 60.50 μ m 72.00 μ m 72.00\,\mu\text{m} 72.00 μ m 84.50 μ m 84.50\,\mu\text{m} 84.50 μ m 98.00 μ m 98.00\,\mu\text{m} 98.00 μ m

− 9.00 D -9.00\text{ D} − 9.00 D 90.75 μ m 90.75\,\mu\text{m} 90.75 μ m 108.00 μ m 108.00\,\mu\text{m} 108.00 μ m 126.75 μ m 126.75\,\mu\text{m} 126.75 μ m 147.00 μ m 147.00\,\mu\text{m} 147.00 μ m

Important

Expanding the optical zone from 6.0 mm 6.0\text{ mm} 6.0 mm to 7.0 mm 7.0\text{ mm} 7.0 mm for a − 6.00 D -6.00\text{ D} − 6.00 D myopic treatment increases the central stromal tissue depth required from 72 μ m 72\,\mu\text{m} 72 μ m to 98 μ m 98\,\mu\text{m} 98 μ m —an additional 36 % 36\% 36% increase in tissue removal ( 98 / 72 = 1.361 98 / 72 = 1.361 98/72 = 1.361 ). Selecting an optical zone smaller than the patient's mesopic pupil diameter causes severe nocturnal glare, starbursts, and loss of contrast sensitivity due to induced spherical aberrations ( Z 4 0 Z_4^0 Z 4 0 ​ ).

2. Photorefractive Keratectomy (PRK) & Advanced Surface Ablation

Surface ablation eliminates corneal tissue directly from the anterior stromal surface after removing or displacing the corneal epithelium, permanently removing Bowman layer. Variations include Photorefractive Keratectomy ( PRK ), Laser Epithelial Keratomileusis ( LASEK ), Epipolis-LASIK ( epi-LASIK ), and Transepithelial PRK ( transPRK ).

Epithelial Debridement Techniques

Mechanical Debridement : Epithelium is scraped centrally using a blunt hockey-knife blade or an automated rotating brush (Amoils brush).

Chemical Debridement (Alcohol-Assisted / LASEK) : A well containing 20 % 20\% 20% dilute ethanol in balanced salt solution is placed on the central cornea for 20 – 30 seconds 20–30\text{ seconds} 20–30 seconds , loosening hemidesmosomal attachments along the basement membrane zone. In classic PRK, the epithelial sheet is discarded; in LASEK, the sheet is folded back and repositioned over the stromal bed following ablation.

Transepithelial PTK/PRK (transPRK) : A single continuous laser sequence where a preliminary phototherapeutic keratectomy (PTK) profile ablates the epithelial layer (typically calibrated to 50 – 55 μ m 50–55\,\mu\text{m} 50–55 μ m centrally) followed immediately by the refractive excimer ablation without manual manipulation.

Corneal Wound Healing & Postoperative Haze Pathogenesis

Epithelial injury in surface ablation initiates an aggressive wound healing cascade:

Damaged epithelial cells release pro-inflammatory cytokines, predominantly interleukin-1 α \alpha α (IL-1 α \alpha α ) , IL-1 β \beta β , and tumor necrosis factor- α \alpha α (TNF- α \alpha α ) .

These cytokines diffuse into the underlying anterior stroma, triggering immediate keratocyte apoptosis across the anterior 50 – 100 μ m 50–100\,\mu\text{m} 50–100 μ m .

Over the subsequent 2 to 4 weeks, surviving quiescent keratocytes in the posterior stroma and periphery proliferate and migrate into the depleted anterior bed under the influence of transforming growth factor- β \beta β (TGF- β \beta β ) and platelet-derived growth factor (PDGF) derived from the regenerating epithelium and tear film.

Activated keratocytes differentiate into myofibroblasts , which express α \alpha α -smooth muscle actin ( α \alpha α -SMA) and secrete abnormal, unorganised type III collagen, biglycan, and decorin, leading to subepithelial reticular opacity known as corneal haze .

Mitomycin C and Surface Healing

Mitomycin C suppresses proliferating cells through DNA cross-linking and may reduce PRK haze in selected higher-risk treatments. Concentration and exposure are protocol-specific; it is not a guarantee against haze. Avoid uncontrolled exposure and protect the endothelium. Follow epithelial closure, infection and pressure, and distinguish haze from recurrent dystrophy or ectasia.

3. Laser In Situ Keratomileusis (LASIK)

In LASIK, a partial-thickness lamellar corneal flap is created and reflected, the exposed intrastromal bed is reshaped with the excimer laser, and the flap is repositioned without sutures. Sparing Bowman layer and the central epithelium provides rapid visual recovery (within 24 hours) and minimal postoperative pain compared to PRK.

Microkeratome vs. Femtosecond Laser Flap Creation

Parameter Mechanical Microkeratome (Blade) Femtosecond Laser (1053 nm Nd:glass)

Mechanism Oscillating motorized stainless steel blade advancing across vacuum suction ring Infrared laser-induced optical breakdown (LIOB); micro-cavitation plasma bubbles of CO 2 \text{CO}_2 CO 2 ​ and H 2 O \text{H}_2\text{O} H 2 ​ O

Flap Morphology Meniscus shape : thinner centrally, thicker in the periphery Planar shape : uniform thickness across entire diameter

Flap Thickness Precision High variability (target 130 – 160 μ m ± 25 – 30 μ m 130–160\,\mu\text{m} \pm 25–30\,\mu\text{m} 130–160 μ m ± 25–30 μ m ) Exceptional reproducibility (target 90 – 110 μ m ± 5 – 10 μ m 90–110\,\mu\text{m} \pm 5–10\,\mu\text{m} 90–110 μ m ± 5–10 μ m )

Side-Cut Architecture Shallow bevelled angle ( 30 ∘ – 45 ∘ 30^\circ–45^\circ 3 0 ∘ –4 5 ∘ ) Customisable vertical or inverted bevelled angle ( 70 ∘ – 110 ∘ 70^\circ–110^\circ 7 0 ∘ –11 0 ∘ )

Biomechanical Stability Lower wound re-apposition strength; higher risk of displacement Superior interlocking flap-bed adhesion; higher tensile resistance

Epithelial Ingrowth Risk Higher ( 1 – 2 % 1–2\% 1–2% ) due to shallow side cuts Significantly lower ( < 0.2 % < 0.2\% < 0.2% ) due to tight vertical/undercut edges

Intraoperative Complications Free caps, buttonholes, incomplete passes Suction loss, Opaque Bubble Layer (OBL), transient light sensitivity

Tip

Inverted bevelled side cuts ( 90 ∘ – 110 ∘ 90^\circ–110^\circ 9 0 ∘ –11 0 ∘ ) created by femtosecond lasers act as a mechanical "manhole cover", preventing sliding displacement and providing superior tectonic resistance against late traumatic dislocation compared to microkeratome flaps.